Showing results (81-90 of 161) with videos related to

Sort By:
Pageof 17
The Journal of Biological Chemistry|December 22, 1999
Rescue of exocytosis in botulinum toxin A-poisoned chromaffin cells by expression of cleavage-resistant SNAP-25. Identification of the minimal essential C-terminal residuesG A O'Sullivan, N Mohammed, P G Foran, et al.
Bioconjugate Chemistry|May 11, 2017
Conjugate of an IgG Binding Domain with Botulinum Neurotoxin A Lacking the Acceptor Moiety Targets Its SNARE Protease into TrkA-Expressing Cells When Coupled to Anti-TrkA IgG or Fc-βNGFMarc Nugent, Jiafu Wang, Gary Lawrence, et al.
Neuropharmacology|March 15, 2013
Therapeutic effectiveness of botulinum neurotoxin A: potent blockade of autonomic transmission by targeted cleavage of only the pertinent SNAP-25Gary W Lawrence, Saak V Ovsepian, Jiafu Wang, et al.
Journal of Molecular Biology|February 19, 2003
Voltage-gated K+ channel from mammalian brain: 3D structure at 18A of the complete (alpha)4(beta)4 complexElena V Orlova, Marianthi Papakosta, Frank P Booy, et al.
Neuropharmacology|July 20, 2007
Concatemers of brain Kv1 channel alpha subunits that give similar K+ currents yield pharmacologically distinguishable heteromersMaxim V Sokolov, Oleg Shamotienko, Sorcha Ní Dhochartaigh, et al.
Neurochemistry International|May 27, 2010
Relationship of acceptors for botulinum neurotoxins (types A and B) in rat CNS with the cholinergic marker, chol-ID M Evans, P J Richardson, A Fine, et al.
The Biochemical Journal|September 21, 2011
Extravesicular intraneuronal migration of internalized botulinum neurotoxins without detectable inhibition of distal neurotransmissionGary W Lawrence, Saak V Ovsepian, Jiafu Wang, et al.
Headache|April 8, 2017
Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: Guidance on Achieving Optimal OutcomesAndrew M Blumenfeld, Stephen D Silberstein, David W Dodick, et al.
Pharmacoepidemiology and Drug Safety|December 5, 2015
Pregnancy outcomes following exposure to onabotulinumtoxinAMitchell F Brin, Russell S Kirby, Anne Slavotinek, et al.
Neurorehabilitation|August 2, 2021
Efficacy and safety of onabotulinumtoxinA with standardized occupational therapy for treatment of pediatric upper limb spasticity: Phase III placebo-controlled randomized trialRozalina Dimitrova, Emily McCusker, Mark Gormley, et al.
Pageof 17